Ftse Mib
33.821,82
0,22%
DAX
17.966,56
0,25%
S&P 500
5.040,79
0,45%
NASDAQ Composite
15.605,48
0,00%
Bitcoin
58.325,51
0,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Molecular Transport Inc (AMTI) Applied Molecular Transport Inc (AMTI) Notizie

Applied Molecular Transport Inc

AMTI
0,263
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/1/202412:12EDGAR2Form 15-12G - Securities registration termination [Section..
03/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202415:15EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
02/1/202415:14EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/12/202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:15BWCyclo Therapeutics, Inc. Completes Merger with Applied..
27/12/202321:49EDGAR2Form 8-K - Current report
26/12/202323:27EDGAR2Form 8-K - Current report
15/12/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/12/202322:05EDGAR2Form 8-K - Current report
27/11/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:16EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
16/11/202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:04EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEApplied Molecular Transport Reports Third Quarter 2023..
25/10/202322:01EDGAR2Form 8-K - Current report
10/10/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202301:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202301:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202317:47EDGAR2Form 425 - Prospectuses and communications, business..
27/9/202317:46EDGAR2Form 8-K - Current report
21/9/202323:12EDGAR2Form 425 - Prospectuses and communications, business..
21/9/202323:10EDGAR2Form 8-K - Current report
21/9/202314:05BWCyclo Therapeutics, Inc. and Applied Molecular Transport..
14/8/202322:15EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEApplied Molecular Transport Reports Second Quarter 2023..
24/7/202322:01EDGAR2Form 8-K - Current report
11/5/202322:05GLOBEApplied Molecular Transport Reports First Quarter 2023..
Apertura: Min: Max:
Chiusura: 0,263

La tua Cronologia

NASDAQ
AMTI
Applied Molecular Transp...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network